Humana (NYSE:HUM) traded ~7% higher in the premarket on Wednesday after the managed care firm, with its Q2 2025 results, ...

Key Takeaways Humana raised its full-year outlook as it anticipates a smaller decline in Medicare Advantage membership than ...

Humana could face $1 billion to $3 billion in losses next year, with the star ratings drop in its Medicare Advantage program.

Humana's Q2 2025 earnings showcase raised EPS guidance, driven by CenterWell Pharmacy outperformance and MA membership gains.

Humana Inc. (NYSE: HUM) touted “solid” second-quarter results and emphasized a multi-year transformation centered on scalable growth, cost reduction and ...

The Kentucky-based company’s results are a bright spot in what’s otherwise been a gloomy quarter for health insurers. Humana ...

Humana raised its annual profit forecast after beating quarterly estimates on Wednesday, as the U.S. health insurer succeeded ...

Humana beat Q2 EPS and revenue estimates and raised its 2025 outlook, driven by strong PDP growth and higher CenterWell ...

Humana is raising its full-year guidance after surpassing revenue expectations in the second quarter, the insurer announced ...

Humana's Q2 earnings fall year over year on a declining membership base. Notably, 2025 adjusted EPS is currently forecasted ...

Humana raised its annual profit forecast on Wednesday, as the U.S. health insurer bets on its efforts to rein in higher ...

Humana Wednesday reported $545 million in second quarter profits as the health insurer’s medical cost trends fell in line ...